These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26238640)

  • 41. Aerosol therapy in patients receiving noninvasive positive pressure ventilation.
    Dhand R
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):63-78. PubMed ID: 22191396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vibrating membrane devices deliver aerosols more efficient than standard devices: a study in a neonatal upper airway model.
    Tiemersma S; Minocchieri S; van Lingen RA; Nelle M; Devadason SG
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):280-6. PubMed ID: 23273244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aerosol device selection: evidence to practice.
    Fink JB
    Respir Care; 2000 Jul; 45(7):874-85. PubMed ID: 10926386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of systemic diseases by inhalation of biomolecule aerosols.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():15-26. PubMed ID: 20134033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in aerosol devices for the delivery of inhaled medications.
    Ari A; Fink JB
    Expert Opin Drug Deliv; 2020 Feb; 17(2):133-144. PubMed ID: 31959028
    [No Abstract]   [Full Text] [Related]  

  • 46. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control.
    Mac Giolla Eain M; Cahill R; MacLoughlin R; Nolan K
    Drug Deliv; 2022 Dec; 29(1):10-17. PubMed ID: 34962221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Device Cleaning and Infection Control in Aerosol Therapy.
    O'Malley CA
    Respir Care; 2015 Jun; 60(6):917-27; discussion 928-30. PubMed ID: 26070583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients.
    Dhand R; Sohal H
    Expert Rev Med Devices; 2008 Jan; 5(1):9-18. PubMed ID: 18095891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted drug-aerosol delivery in the human respiratory system.
    Kleinstreuer C; Zhang Z; Donohue JF
    Annu Rev Biomed Eng; 2008; 10():195-220. PubMed ID: 18412536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung.
    Dolovich MA
    Respir Care; 2000 Jun; 45(6):597-608. PubMed ID: 10894453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development challenges and opportunities in aerosol drug delivery systems in non-invasive ventilation in adults.
    Reychler G; Michotte JB
    Expert Opin Drug Deliv; 2019 Feb; 16(2):153-162. PubMed ID: 30658045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
    O'Riordan TG; Amram JC
    J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhaler devices: what remains to be done?
    Smith IJ; Bell J; Bowman N; Everard M; Stein S; Weers JG
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S25-37. PubMed ID: 21133798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: an in vitro study.
    Murgia X; Gastiasoro E; Mielgo V; Alvarez-Diaz F; Lafuente H; Valls-i-Soler A; Gomez-Solaetxe MA; Larrabe JL; Rey-Santano C
    J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):81-7. PubMed ID: 21410324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging aerosol drug delivery strategies: from bench to clinic.
    Rubin BK; Williams RW
    Adv Drug Deliv Rev; 2014 Aug; 75():141-8. PubMed ID: 24993613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Consensus statement: aerosols and delivery devices. American Association for Respiratory Care.
    Dolovich MA; MacIntyre NR; Anderson PJ; Camargo CA; Chew N; Cole CH; Dhand R; Fink JB; Gross NJ; Hess DR; Hickey AJ; Kim CS; Martonen TB; Pierson DJ; Rubin BK; Smaldone GC
    Respir Care; 2000 Jun; 45(6):589-96. PubMed ID: 10894452
    [No Abstract]   [Full Text] [Related]  

  • 58. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro evaluation of aerosol delivery by different nebulization modes in pediatric and adult mechanical ventilators.
    Wan GH; Lin HL; Fink JB; Chen YH; Wang WJ; Chiu YC; Kao YY; Liu CJ
    Respir Care; 2014 Oct; 59(10):1494-500. PubMed ID: 24865422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.